Daily News for Neuros, Nurses & Savvy MSers: 208,152 Viewers, 8,368 Stories & Studies
Click Here For My Videos, Advice, Tips, Studies and Trials.
Timothy L. Vollmer, MD
Department of Neurology
University of Colorado Health Sciences Center Professor

Co-Director of the RMMSC at Anschutz Medical Center

Medical Director-Rocky Mountain MS Center
Click here to read my columns
Brian R. Apatoff, MD, PhD
Multiple Sclerosis Institute
Center for Neurological Disorders

Associate Professor Neurology and Neuroscience,

Weill Medical College of Cornell University

Clinical Attending in Neurology,
New York-Presbyterian Hospital
You'll get FREE Breaking News Alerts on new MS treatments as they are approved

HERE'S A FEW OF OUR 6000+ Facebook & MySpace FRIENDS
Timothy L. Vollmer M.D.
Department of Neurology
University of Colorado Health Sciences Center
Co-Director of the RMMSC at Anschutz Medical Center
Medical Director-Rocky Mountain MS Center

Click to view 1280 MS Walk photos!

"MS Can Not
Rob You of Joy"
"I'm an Mom has MS and we have a message for everyone."
- Jennifer Hartmark-Hill MD
Beverly Dean

"I've had MS for 2 years...this is the most important advice you'll ever hear."
"This is how I give myself a painless injection."
Heather Johnson

"A helpful tip for newly diagnosed MS patients."
"Important advice on choosing MS medication "
Joyce Moore

This page is powered by Blogger. Isn't yours?



University Life: Sweet treat in trial to help reduce symptoms of MS

Dr Shelly Coe and Prof Helen Dawes will be leading research at Oxford Brookes to see if a compound found in dark chocolate can help to reduce fatigue in people with MS

Back in November, the MS Society granted Oxford Brookes £75,000 to carry out a research project to assess whether pure hot chocolate can help to reduce the symptoms of Multiple Sclerosis.

Professor Helen Dawes and I will be leading a research team who will be looking specifically at whether a compound found in dark chocolate can help to reduce fatigue in people with MS – one of the most common symptoms of the condition.

There is currently no cure for fatigue and one of the MS Society’s top 10 priorities is to understand which treatments are effective for fatigue in those with MS.

There is currently a similar pilot trial going on at Oxford Brookes, which includes two of our undergraduate final year students.

Dark cocoa containing 70-85 per cent cocoa solid is well known for its high antioxidant and flavonoid content.

Acute dark cocoa consumption has been shown to actively improve fatigue in those with chronic fatigue syndrome (CFS) or ME and this was thought to be due to the flavonoid compounds.

However, no studies to date have assessed the role of flavonoids or flavonoid-rich dark cocoa for improving fatigue in those with MS.

Previous studies have been mostly observational, cross-sectional studies with inclusive results for determining the best nutritional interventions for symptom management in MS.

Patients, carers and clinicians agree that fatigue is a severely debilitating symptom and while there is no medication to treat fatigue, simple approaches such as diet can be used to reduce its severity.

Dietary changes may be simple, cost effective and safe therapy for improving symptoms experienced in people with MS, and thus for increasing quality of life.

Dark chocolate is generally seen as a food that’s bad but it has good things in it – including flavonoids.

We have consulted external experts for feedback about this project, including those at MS support groups and medics and the response overall has been very positive.

Forty people with the relapsing form of MS will be given hot chocolate daily over six weeks – half will get a flavonoid-rich cocoa drink and the others will get a cocoa drink with low levels of flavonoids.

Specifically, we will be looking at the impact of cocoa flavonoids on inflammation and the role that plays in fatigue.

Those taking part in the study will fill in questionnaires about their fatigue levels, take part in walking tests and provide blood samples so we can check for signs of inflammation and free radical damage.

The participants will also wear accelerometers – watches that monitor their activity levels.

Two-thirds of MS diagnoses occur in young adults between the ages of 20 and 40 who are at the peak of their career and family development.

We are therefore recruiting those who are newly diagnosed with the disease, and predict the majority of patients to be under the age of 35.

We will be recruiting patients from the John Radcliffe Hospital and also through advertisement at Thames Valley MS community venues, clinics and support groups.

Story Source: The above story is based on materials provided by OXFORDMAIL
Note: Materials may be edited for content and length 
Clickhere to read more


Go to Newer News Go to Older News